Lupin, Novartis Drop Patent Dispute Over Lotrel
Novartis Corp. and Lupin Ltd. have dropped a long-running dispute over a patent for Lotrel, making the Indian generics manufacturer the latest to exit litigation over the pharmaceutical giant's billion-dollar hypertension...To view the full article, register now.
Already a subscriber? Click here to view full article